Adam M Veness insider trades: Dianthus Therapeutics (DNTH) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Adam reports to the SEC
Open-market buys and sales
11 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 10, 2026 | DNTH | ↓ Sell | 20,000 | $110.44 | $2.2M | Direct | Aug 11, 2026 (1d) |
| Jun 17, 2026 | DNTH | ↓ Sell | 30,000 | $80.80 | $2.4M | Direct | Jun 18, 2026 (1d) |
| Sep 21, 2021 | XLRN | ↓ Sell | 6,650 | $150.05 | $998K | Direct | Sep 22, 2021 (1d) |
| Sep 9, 2021 | XLRN | ↓ Sell | 1,413 | $130.00 | $184K | Direct | Sep 9, 2021 (0d) |
| Jan 5, 2021 | XLRN | ↓ Sell | 2,056 | $122.56 | $252K | Direct | Jan 6, 2021 (1d) |
| Sep 8, 2020 | XLRN | ↓ Sell | 2,000 | $89.50 | $179K | Direct | Sep 9, 2020 (1d) |
| Apr 8, 2020 | XLRN | ↓ Sell | 6,000 | $85.58 | $514K | Direct | Apr 10, 2020 (2d) |
| Jan 3, 2020 | XLRN | ↓ Sell | 1,309 | $51.76 | $68K | Direct | Jan 3, 2020 (0d) |
| Sep 10, 2019 | XLRN | ↓ Sell | 824 | $45.20 | $37K | Direct | Sep 10, 2019 (0d) |
| Aug 9, 2019 | XLRN | ↓ Sell | 3,268 | $45.00 | $147K | Direct | Aug 12, 2019 (3d) |
| Jul 16, 2019 | XLRN | ↓ Sell | 538 | $40.71 | $22K | Direct | Jul 17, 2019 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other DNTH insiders
Open-market trades in the last 12 months
About Adam M Veness's insider trades
Adam M Veness is SVP, General Counsel and Sec. at Dianthus Therapeutics (DNTH). Since Jul 16, 2019, Adam has reported no open-market purchases and 11 sales worth $7.0M on SEC Form 4. In the last 12 months: 2 sales ($4.6M).
Their filings also include grants and awards (9 filings), option exercises (6 filings), shares withheld for taxes (3 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every DNTH insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.